Patent · US Active

Benzothiazolone compound

US10251868B2 · kind B2 · utility

0Cited by

1References

22Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Jun CAO · Hoherlehmer Straße, CN
Bernhard Erb · Gipf-Oberfrick, CH
Robin Alec Fairhurst · Riehen, CH
Arnaud GRANDEURY · Helfrantzkirch, FR
Shinji Hatakeyama · Ibaraki, JP
Magdalena KOZICZAK-HOLBRO · Basel, CH
Xinzhong Lai · Hoherlehmer Straße, CN
Philipp Lustenberger · Warthausen, DE
Bernd Ulrich Riebesehl · Soest, DE
Nicola Tufilli
Thomas Ullrich · Bottmingen, CH
Xiang WU · Hubei, CN
Jianguang Zhou · 林湖乡, CN

Key dates

Filing date	Jan 22, 2018
Grant date	Apr 9, 2019
Priority date	—
Expiry date	Jan 22, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form a method for manufacturing the compound of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.